NEW YORK, Feb. 17, 2011 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating potential claims on behalf of investors of Emergency Medical Services Corp. ("EMS" or the "Company") (NYSE:EMS) against the Company's board of directors in connection with the proposed acquisition of the Company by an affiliate of private equity firm Clayton, Dubilier & Rice, LLC. The proposed transaction is valued at approximately $3.2 billion. EMS investors are advised to contact Rachelle R. Boyle at 888-476-6529 or rrboyle@pomlaw.com.
Under the terms of the definitive merger agreement, EMS stockholders will receive $64.00 in cash for each share of EMS Class A common stock and Class B common stock and each LP Exchangeable Unit they own. The price is a 9.4% discount of EMS's closing price of $70.66 on February 11, 2011. In addition, Onex Corporation and its affiliates, holders of EMS's LP Exchangeable Units, have agreed to vote in favor of the merger agreement and have sufficient voting power to approve the merger. The investigation is focused on the potential unfairness of the price to the Company's shareholders and the process by which the board of directors considered the transaction.
The Pomerantz Firm, with offices in New York, Chicago and Washington, D.C., is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .
CONTACT: Rachelle R. Boyle Pomerantz Haudek Grossman & Gross LLP Phone: (888) 476.6529 (888) 4.POMLAW rrboyle@pomlaw.com